Power-PD
Research type
Research Study
Full title
Power-PD: EmPOWERing people with Parkinson’s Disease through flexible hybrid exercise - a randomised feasibility study with pre and post-test design.
IRAS ID
329635
Contact name
Pushpsen Joshi
Contact email
Sponsor organisation
University College London
Clinicaltrials.gov Identifier
Z6364106/2025/11/02, UCL Data Protection Registration Number
Duration of Study in the UK
1 years, 6 months, 31 days
Research summary
Parkinson's affects the body’s nervous system. It causes people to feel stiff, shake and have difficulty walking and keeping their balance. Exercise is helpful, but people with Parkinson's exercise less. They say they need support to exercise regularly, especially if they have trouble walking or don’t live near to an exercise group. An online exercise group could support people to be physically active, which can become a habit to manage their Parkinson's. But exercising online makes it difficult to talk to and see each other. People with Parkinson's want flexible and hybrid options for exercise. This is supported by other research. A flexible exercise group could allow people choice to attend in-person with other people or online from home. This might help empower people with Parkinson's to exercise regularly.
To understand this, we will design and deliver a study which tests whether a combined (hybrid) exercise intervention (Power-PD) is possible, and importantly if it is an intervention people want and need. Power-PD is an exercise group for people with Parkinson's designed to offer flexible access through either attending in-person or remotely from home and develop long-term exercise habits.
Power-PD is for people with mild to moderate Parkinson's who do not have severe difficulty with their walking and balance. Participants will attend Power-PD 1x per week for 12 weeks. It will include up-to 60-minutes of exercise and up-to 30-minutes for participants to talk together about how to exercise more regularly. Information from participants and instructors delivering it will be gathered to see how well Power-PD is carried out. This will tell us if Power-PD should be explored as a larger clinical trial.
REC name
London - Queen Square Research Ethics Committee
REC reference
26/LO/0321
Date of REC Opinion
7 May 2026
REC opinion
Further Information Favourable Opinion